v3.26.1
Share-Based Payment Arrangements
6 Months Ended
Jun. 27, 2026
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Payment Arrangements
(2)
Share-based Payment Arrangements
As of June 27, 2026, the Company has an employee equity incentive plan, the 2011 equity incentive plan (the “2011 EIP”). The Company also has a stock compensation plan for members of its Board of Directors, the 2022 Directors Stock Compensation Plan (the “2022 DSCP”). 6,000,000 shares of the Company’s common stock were authorized for issuance under the 2011 EIP and 200,000 shares of the Company’s common stock were authorized for issuance under the 2022 DSCP. The 2011 EIP and 2022 DSCP are each referred to herein as a “Plan,” and, collectively, as the “Plans.” Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):
 
    
Twenty-Six Weeks Ended
    
Thirteen Weeks Ended
 
    
June 27,

2026
    
June 28,

2025
    
June 27,

2026
    
June 28,

2025
 
Total cost of the Plans during the period
   $ 5,420      $ 3,657      $ 2,933      $ 1,619  
Amount of related income tax benefit recognized during the period
     (1,341      (792      (883      (344
  
 
 
    
 
 
    
 
 
    
 
 
 
Net cost of the Plans during the period
   $ 4,079      $ 2,865      $ 2,050      $ 1,275  
  
 
 
    
 
 
    
 
 
    
 
 
 
Included in income tax benefits recognized in the
twenty-six-week
periods ended June 27, 2026 and June 28, 2025 were tax (benefits) deficiencies from stock-based awards of ($14,000) and $104,000, respectively.
As of June 27, 2026, there were 161,928 shares of the Company’s common stock reserved for issuance under the 2022 DSCP and 2,600,923 shares of the Company’s common stock reserved for issuance under the 2011 EIP.
Restricted Stock Units
The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:
 
    
Number of
RSUs
    
Weighted Average

Grant Date
Fair Value
 
Outstanding at December 27, 2025
     203,712      $ 143.95  
Granted
     61,940      $ 134.35  
Forfeited
     (42,744    $ 154.46  
  
 
 
    
Outstanding at June 27, 2026
     222,908      $ 139.27  
  
 
 
    
During the
twenty-six-week
period ended June 27, 2026, the Company granted RSUs with a performance condition and RSUs with a market condition, as further described below. Outstanding RSUs at both December 27, 2025 and June 27, 2026 include RSUs with a performance condition and RSUs with a market condition, as further described below and in the Company’s 2025 Annual Report on Form
10-K.
RSUs with a performance condition granted during the
twenty-six-week
period ended June 27, 2026 may vest on January 31 of 2029, 2030 and 2031 based on growth in diluted earnings per share as compared to the results from the 2025 fiscal year, adjusted to reflect the add back of (i) the charge taken by the Company in the 2025 first quarter in connection with a supply chain fraud relating to the Company’s international freight forwarding operations; and (ii) impairment charges recorded in the Company’s 2025 fiscal year related to: the decision to actively market for sale Landstar Metro, S.A.P.I. de C.V., the Company’s wholly-owned Mexican operating subsidiary; the decision to wind-down the Landstar Blue TMS; and
a non-controlling equity
investment made by the Company in Cavnue, LLC, a privately held
technology start-up company.
On January 30, 2026, the Company granted 6,715 RSUs that vest based on a market condition. These RSUs may vest based on the achievement of a specific total shareholder return (“TSR”) compound annual growth rate, adjusted to reflect dividends (if any) paid during such periods and capital adjustments as may be necessary, and are eligible to vest annually starting after the sixth anniversary of the grant date and concluding after the tenth anniversary of the grant date. The fair value of this RSU award was determined at the time of grant based on the expected achievement of the market condition. With respect to these RSU awards, the Company reports compensation expense ratably over the service period of the award based on the number of units granted multiplied by the grant date fair value of the RSU. Previously recognized compensation cost would be reversed only if the employee did not complete the requisite service period due to termination of employment.
 
The Company recognized approximately $3,022,000 and $1,253,000 of share-based compensation expense related to RSU awards in the
twenty-six-week
periods ended June 27, 2026 and June 28, 2025, respectively. As of June 27, 2026, there was a maximum of $47.9 million of total unrecognized compensation cost related to RSU awards granted under the Plans with an expected average remaining life of approximately 3.1 years. With respect to RSU awards with a performance condition, the amount of future compensation expense to be recognized will be determined based on future operating results.
Non-vested
Restricted Stock and Deferred Stock Units
The following table summarizes information regarding the Company’s outstanding shares of
non-vested
restricted stock and Deferred Stock Units (defined below) under the Plans:
 
    
Number of Shares

and Deferred Stock
Units
    
WeightedAverage

Grant Date

Fair Value
 
Non-vested
at December 27, 2025
     53,776      $ 168.95  
Granted
     36,135      $ 155.77  
Vested
     (31,570    $ 167.44  
Forfeited
     (4,354    $ 164.93  
  
 
 
    
Non-vested
at June 27, 2026
     53,987      $ 161.33  
  
 
 
    
The fair value of each share of
non-vested
restricted stock issued and Deferred Stock Unit granted under the Plans is based on the fair value of a share of the Company’s common stock on the date of grant. Shares of
non-vested
restricted stock are generally subject to vesting in three equal annual installments either on the first, second and third anniversary of the date of the grant or the third, fourth and fifth anniversary of the date of the grant, in two equal annual installments on the first and second anniversary of the date of the grant or 100% on the first or third anniversary of the date of the grant. For restricted stock awards granted under the 2022 DSCP, each recipient may elect to defer receipt of shares and instead receive restricted stock units (“Deferred Stock Units”), which represent contingent rights to receive shares of the Company’s common stock on the date of the recipient’s separation from service from the Board of Directors, or, if earlier, upon a change in control event of the Company. Deferred Stock Units become vested 100% on the first anniversary of the date of the grant. Deferred Stock Units do not represent actual ownership in shares of the Company’s common stock and the recipient does not have voting rights or other incidents of ownership until the shares are issued. However, Deferred Stock Units do contain the right to receive dividend equivalent payments prior to settlement into shares.
As of June 27, 2026, there was $7,061,000 of total unrecognized compensation cost related to
non-vested
shares of restricted stock and Deferred Stock Units granted under the Plans. The unrecognized compensation cost related to these
non-vested
shares of restricted stock and Deferred Stock Units is expected to be recognized over a weighted average period of 2.0 years.